2021
DOI: 10.1016/j.ijpddr.2021.05.001
|View full text |Cite
|
Sign up to set email alerts
|

In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocysts

Abstract: Bumped kinase inhibitors (BKIs) target the apicomplexan calcium-dependent protein kinase 1 (CDPK1). BKI-1748, a 5-aminopyrazole-4-carboxamide compound when added to fibroblast cells concomitantly to the time of infection, inhibited proliferation of apicomplexan parasites at EC 50 s of 165 nM ( Neospora caninum) and 43 nM ( Toxoplasma gondii) . Immunofluorescence and electron microscopy showed that addition of 2.5 μM BKI-1748 to infected HFF m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
35
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 19 publications
(40 citation statements)
references
References 40 publications
4
35
1
Order By: Relevance
“…The treatment with 10 mg/kg ELQ-334 and 10 mg/kg ELQ-422 resulted in only little neonatal mortality (two out of 11 and one out of 17 pups, respectively). As previously reported, BKI-1748 applied at 20 mg/kg/day did not impair fertility rates or pup survival ( Imhof et al, 2021 ). However, the combination treatments appeared to induce neonatal pup mortality to a higher degree (mortality of five out of 11 and three out of 19 pups for the combined ELQ-334 + BKI-1748 and ELQ-422 + BKI-1748 treatments, respectively), which raised some safety concerns.…”
Section: Resultssupporting
confidence: 85%
See 4 more Smart Citations
“…The treatment with 10 mg/kg ELQ-334 and 10 mg/kg ELQ-422 resulted in only little neonatal mortality (two out of 11 and one out of 17 pups, respectively). As previously reported, BKI-1748 applied at 20 mg/kg/day did not impair fertility rates or pup survival ( Imhof et al, 2021 ). However, the combination treatments appeared to induce neonatal pup mortality to a higher degree (mortality of five out of 11 and three out of 19 pups for the combined ELQ-334 + BKI-1748 and ELQ-422 + BKI-1748 treatments, respectively), which raised some safety concerns.…”
Section: Resultssupporting
confidence: 85%
“…Three hours after infection, coverslips were treated either with 1 μM ELQ-422, 2.5 μM BKI-1748, or 1 μM ELQ-422 + 2.5 μM BKI-1748, and the cultures were further maintained in the presence of the drugs. Immunofluorescence staining was carried out as described ( Imhof et al, 2021 ). Briefly, at different time points, the coverslips were washed once in PBS, fixed in 3% paraformaldehyde in PBS (pH 7.2) for 10 min, and permeabilized in a 1:1 solution of pre-cooled methanol/acetone at −20 °C ( Alaeddine et al, 2013 ; Guionaud et al, 2010 ; Winzer et al, 2015 ).…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations